- Darren Day has been appointed as Chief Executive Officer, effective immediately
- Mr. Day brings a strong background in business management, legal, and financing
- He obtained a bachelor’s degree at BYU holds a JD MBA from UNC-Chapel Hill
- Mr. Day’s primary responsibilities will be to help steer the Carotid Stenotic Scan (CSS) through FDA clearance and introduce it to the marketplace
- The CSS is a patented device designed to detect and measure carotid arterial stenosis
- CVR Medical Corp. (CVM) is down 16.67 per cent, trading at C$0.025 per share at 3:15 pm ET
CVR Medical (CVM) is pleased to announce the appointment of Darren Day as Chief Executive Officer, effective immediately.
Mr. Day brings an entrepreneurial background in business management, legal, and financing. Darren has managed a successful law firm for over 14 years.
He obtained a bachelor’s degree at BYU and continued to law school at UNC-Chapel Hill where he graduated with a JD MBA.
Mr. Day comes to CVR Medical Corp. with the goal of bringing the Carotid Stenotic Scan (CSS) through FDA clearance.
Darren will help the company take important strides toward a successful introduction of the CSS to the marketplace and with the right strategies and focused execution will be able to unlock CVR Medical’s potential.
CVR Medical Corp. is a healthcare company focused on the commercialization of its proprietary Carotid Stenotic Scan device (CSS). The CSS is a patented device designed to detect and measure carotid arterial stenosis.
CVR Medical Corp. (CVM) is down 16.67 per cent, trading at C$0.025 per share at 3:15 pm ET.
